SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-06-131656
Filing Date
2006-06-19
Accepted
2006-06-19 08:58:30
Documents
3
Period of Report
2006-07-26
Effectiveness Date
2006-06-19

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 245252
2 GRAPHIC g70920g67a67.jpg GRAPHIC 12116
3 GRAPHIC g70920g67d86.jpg GRAPHIC 7997
  Complete submission text file 0001193125-06-131656.txt   274838
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15070 | Film No.: 06911614
SIC: 2834 Pharmaceutical Preparations